Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 3, 2005, Pages 695-703

  Quan, Aimee L ^a   Barnett, Gene H ^a   Lee, Shih Yuan ^a   Vogelbaum, Michael A ^a   Toms, Steven A ^a   Staugaitis, Susan M ^a   Prayson, Richard A ^a   Peereboom, David M ^a   Stevens, Glen H J ^a   Cohen, Bruce H ^a   Suh, John H ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Epidermal growth factor receptor; Glioblastoma multiforme; Malignant glioma

Indexed keywords

DOSIMETRY; ONCOLOGY; PATIENT TREATMENT;

EPIDERMAL GROWTH FACTOR RECEPTORS; MALIGNANT GLIOMA; MULTIVARIATE ANALYSIS;

PATIENT MONITORING;

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; CANCER SURVIVAL; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOGRAPHY; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 25844521171     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.051     Document Type: Article

References (37)

1. U. Hoi Sang, O.D. Espiritu, P.Y. Kelley The role of the epidermal growth factor receptor in human gliomas: I. The control of cell growth J Neurosurg 82 1995 841 846
2. E. Jaros, R.H. Perry, L. Adam Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours Br J Cancer 66 1992 373 385
3. J. Schlegel, A. Merdes, G. Stumm Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma Int J Cancer 56 1994 72 77
4. A. Waha, A. Baumann, H.K. Wolf Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas J Neurosurg 85 1996 634 641
5. M.C. Etienne, J.L. Formento, C. Lebrun-Frenay Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome Clin Cancer Res 4 1998 2383 2390
6. S.H. Bigner, P.C. Burger, A.J. Wong Gene amplification in malignant human gliomas Clinical and histopathologic aspects J Neuropathol Exp Neurol 47 1988 191 205
7. M.R. Hurtt, J. Moossy, M. Donovan-Peluso Amplification of epidermal growth factor receptor gene in gliomas Histopathology and prognosis J Neuropathol Exp Neurol 51 1992 84 90
8. S.H. Torp, E. Helseth, A. Dalen Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas Acta Neurochir (Wien) 117 1992 182 186
9. N.L. Dorward, R.A. Hawkins, I.R. Whittle Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma Br J Neurosurg 7 1993 197 199
10. E.M. Hiesiger, R.L. Hayes, D.M. Pierz Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs) J Neurooncol 16 1993 93 104
11. U. Diedrich, J. Lucius, E. Baron Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis J Neurol 242 1995 683 688
12. R. Schober, T. Bilzer, A. Waha The epidermal growth factor receptor in glioblastoma Genomic amplification, protein expression, and patient survival data in a therapeutic trial Clin Neuropathol 14 1995 169 174
13. A. Zhu, J. Shaeffer, S. Leslie Epidermal growth factor receptor An independent predictor of survival in astrocytic tumors given definitive irradiation Int J Radiat Oncol Biol Phys 34 1996 809 815
14. P. Korkolopoulou, P. Christodoulou, K. Kouzelis MDM2 and p53 expression in gliomas A multivariate survival analysis including proliferation markers and epidermal growth factor receptor Br J Cancer 75 1997 1269 1278
15. N.G. Rainov, K.U. Dobberstein, H. Bahn Prognostic factors in malignant glioma Influence of the overexpression of oncogene and tumor-suppressor gene products on survival J Neurooncol 35 1997 13 28
16. J.J. Olson, D. Barnett, J. Yang Gene amplification as a prognostic factor in primary brain tumors Clin Cancer Res 4 1998 215 222
17. C. Bouvier-Labit, O. Chinot, C. Ochi Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas Neuropathol Appl Neurobiol 24 1998 381 388
18. E.W. Newcomb, H. Cohen, S.R. Lee Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or bcl-2 genes Brain Pathol 8 1998 655 667
19. A. Korshunov, A. Golanov, R. Sycheva Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas An analysis of 168 cases J Clin Pathol 52 1999 574 580
20. M. Huncharek, B. Kupelnick Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme Results of a meta-analysis Oncol Res 12 2000 107 112
21. F.G. Barker 2nd, M.L. Simmons, S.M. Chang EGFR overexpression and radiation response in glioblastoma multiforme Int J Radiat Oncol Biol Phys 51 2001 410 418
22. M.L. Simmons, K.R. Lamborn, M. Takahashi Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients Cancer Res 61 2001 1122 1128
23. A. Chakravarti, M.A. Delaney, E. Noll Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas Clin Cancer Res 7 2001 2387 2395
24. J.S. Smith, I. Tachibana, S.M. Passe PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme J Natl Cancer Inst 93 2001 1246 1256
25. M.C. Schmidt, S. Antweiler, N. Urban Impact of genotype and morphology on the prognosis of glioblastoma J Neuropathol Exp Neurol 61 2002 321 328
26. N. Shinojima, K. Tada, S. Shiraishi Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme Cancer Res 63 2003 6962 6970
27. E.A. Maher, F.B. Furnari, R.M. Bachoo Malignant glioma Genetics and biology of a grave matter Genes Dev 15 2001 1311 1333
28. E.G. Shaw, W. Seiferheld, C. Scott Reexamining the Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients [Abstract] Int J Radiat Oncol Biol Phys 57 Suppl. 2 2003 S135 S136
29. K.D. Aldape, K. Ballman, A. Furth Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance J Neuropathol Exp Neurol 63 2004 700 707
30. S.A. Schwartz, R.J. Weil, M.D. Johnson Protein profiling in brain tumors using mass spectrometry Feasibility of a new technique for the analysis of protein expression Clin Cancer Res 10 2004 981 987
31. K.S. Yoon, M.C. Lee, S.S. Kang p53 mutation and epidermal growth factor receptor overexpression in glioblastoma J Korean Med Sci 16 2001 481 488
32. A.J. Wong, S.H. Bigner, D.D. Bigner Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification Proc Natl Acad Sci U S A 84 1987 6899 6903
33. R. Kordek, W. Biernat, J. Alwasiak p53 protein and epidermal growth factor receptor expression in human astrocytomas J Neurooncol 26 1995 11 16
34. W. Liu, C.D. James, L. Frederick PTEN/MMAC1 mutations and EGFR amplification in glioblastomas Cancer Res 57 1997 5254 5257
35. A.P. Dicker, U. Rodeck Targeting the EGFR in neoplasia - more questions than answers Int J Radiat Oncol Biol Phys 58 2004 899 902
36. J. Dancey Epidermal growth factor receptor inhibitors in clinical development Int J Radiat Oncol Biol Phys 58 2004 1003 1007
37. A. Chakravarti, W. Seiferheld, H. Robins An update of phase I data from RTOG 0211 A phase I/II clinical study of gefitinib + radiation for newly-diagnosed glioblastoma (GBM) patients [Abstract] Proc Am Soc Clin Oncol 22 2004 124